Loading…

Protocol - Clinician-Administered Psychiatric Assessment

Add to My Toolkit
Description

The Structured Clinical Interview for DSM-5® Disorders-Clinician Version (SCID-5-CV) is a clinician-administered, semi-structured interview guide for making diagnoses using the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5).

Specific Instructions

None

Availability

Limited Availability

Protocol

The Structured Clinical Interview for DSM-5® Disorders-Clinician Version (SCID-5-CV) is a clinician-administered, semi-structured interview guide for making diagnoses using the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5). The SCID-5-CV covers the DSM-5 diagnoses most often encountered in the clinic, including depressive and bipolar disorders, schizophrenia spectrum and other psychotic disorders, substance use disorders, anxiety disorders (panic disorder, agoraphobia, social anxiety disorder, generalized anxiety disorder), obsessive-compulsive disorder, posttraumatic stress disorder, attention-deficit/hyperactivity disorder, and adjustment disorder. It also screens for 17 additional DSM-5 disorders.

The SCID-5-CV can be used to ensure that the major DSM-5 diagnoses are evaluated, to select study populations, and characterize current and previous psychiatric diagnoses.

The SCID-5-CV is a proprietary instrument and administration requires a license from the American Psychiatric Association:

https://www.appi.org/products/structured-clinical-interview-for-dsm-5-scid-5

Personnel and Training Required

The Structured Clinical Interview for DSM-5® Disorders-Clinician Version (SCID-5-CV) should be administered by a clinician or trained mental health professional who has had experience performing unstructured diagnostic evaluations.

Equipment Needs

None

Requirements
Requirement CategoryRequired
Major equipment No
Specialized training Yes
Specialized requirements for biospecimen collection No
Average time of greater than 15 minutes in an unaffected individual Yes
Mode of Administration

Clinician-administered interview

Lifestage

Adolescent, Adult

Participants

Adolescents and adults, ages 12 and older

Selection Rationale

The Structured Clinical Interview for DSM-5® Disorders-Clinician Version (SCID-5-CV) is the gold standard for diagnosing most psychiatric diseases encountered in a clinical setting according to Diagnostic and Statistical Manual of Mental Disorders (DSM) criteria.

Language

English

Standards
StandardNameIDSource
Human Phenotype Ontology Behavioral abnormality HP:0000708 HPO
Derived Variables

None

Process and Review

Not applicable.

Protocol Name from Source

Structured Clinical Interview for DSM-5 Disorders - Clinician Version (SCID-5-CV)

Source

First, M. B., Williams, J. B., Karg, R. S., & Spitzer, R. L. (2015). Structured Clinical Interview for DSM-5® Disorders-Clinician Version (SCID-5-CV) Washington, DC: American Psychiatric Association.

The SCID-5-CV is a proprietary instrument and administration requires a license from the American Psychiatric Association: https://www.appi.org/products/structured-clinical-interview-for-dsm-5-scid-5

General References

Dreessen, L., Hildebrand, M., & Arntz, A. (1998). Patient-informant concordance on the Structured Clinical Interview for DSM-III-R personality disorders (SCID-II). Journal of Personality Disorders, 12(2), 149-161.

Fennig, S., Bromet, E. J., Jandorf, L., Schwartz, J. E., Lavelle, J., & Ram, R. (1994). Eliciting psychotic symptoms using a semi-structured diagnostic interview. The importance of collateral sources of information in a first- admission sample. Journal of Nervous & Mental Disease, 182(1), 20-26.

First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (1995). The Structured Clinical Interview for DSM-III-R Personality Disorders (SCID-II), Part I: Description. Journal of Personality Disorders, 9(2), 83-91.

Rohde, P., Lewinsohn, P. M., & Seeley, J. R. (1997). Comparability of telephone and face-to-face interviews in assessing axis I and II disorders. American Journal of Psychiatry, 154(11), 1593-1598.

Scarvalone, P. A., Cloitre, M., Spielman, L. A., Jacobsberg, L., Fishman, B., & Perry, S. W. (1996). Distress reduction during the Structured Clinical Interview for DSM-III-R. Psychiatry Research, 59(3), 245-249.

Spitzer, R. L., Williams, J. B., Gibbon, M., & First, M. B. (1992). The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Archives of General Psychiatry, 49(8), 624-629.

Ventura, J., Liberman, R. P., Green, M. F., Shaner, A., & Mintz, J. (1998). Training and quality assurance with the structured clinical interview for DSM-IV (SCID-I/P). Psychiatry Research, 79(2), 163-173.

Protocol ID

662501

Variables
Export Variables
Variable Name Variable IDVariable DescriptiondbGaP Mapping
PX662501000000 Protocol 662501 - proprietary. Check DCW for more
contact. show less
N/A
Early Psychosis Translational Research
Measure Name

Clinician-Administered Psychiatric Assessment

Release Date

January 17, 2017

Definition

A structured interview guide for making diagnoses using the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5).

Purpose

This measure can be used to ensure that major Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5), diagnoses are evaluated; to select study populations; to study the effectiveness of treatments and interventions; and to characterize a population in terms of current and previous psychiatric diagnoses.

Keywords

early psychosis, structured clinical interview for DSM-5, SCID-5, depression, anxiety, insomnia, Sleep, Obsessive-compulsive disorder, memory, Personality traits, psychosis, anger, Substance abuse and dependence, repetitive thoughts and behaviors, suicide, American Psychiatric Association, APA, Diagnostic and Statistical Manual of Mental Disorders (5th ed.), DSM-5, gerontology, aging, geriatrics

Measure Protocols
Protocol ID Protocol Name
662501 Clinician-Administered Psychiatric Assessment
Publications

Conway, K. P., et al. (2018) Co-occurrence of tobacco product use, substance use, and mental health problems among youth: Findings from wave 1 (2013-2014) of the population assessment of tobacco and health (PATH) study. Addict Behav. 2018 January; 76: 208-217. doi: 10.1016/j.addbeh.2017.08.009